| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T187 |
0-20 |
Sentence |
denotes |
Other Considerations |
| T188 |
21-192 |
Sentence |
denotes |
Critical considerations for diagnostics used for epidemic diseases of public health importance include the quality assurance and regulatory frameworks surrounding testing. |
| T189 |
193-409 |
Sentence |
denotes |
Mature regulatory agencies have developed mechanisms to account for emergencies, such as the FDA's EUA stream, but pragmatic solutions must be found to facilitate wide-scale, independent evaluation of emerging tests. |
| T190 |
410-571 |
Sentence |
denotes |
Initially, the need for elaborate biosafety precautions and inconsistent recommendations for their application across regions severely hampered COVID-19 testing. |
| T191 |
572-1000 |
Sentence |
denotes |
Although these continue to evolve, current recommendations in Canada and the United States acknowledge that nonpropagative work for molecular testing may be performed in containment level 2 conditions found in routine diagnostic laboratories and provide specific guidance on diagnostic testing of specimens conducted outside a biosafety level 2 laboratory, such as rapid respiratory testing performed at the point of care (67) . |
